Nirowin-2.6 mg CR Tablet 30's
₹144*
MRP ₹160
10% off
₹136*
MRP ₹160
15% CB
₹24 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Nirowin-2.6 mg CR Tablet is used to prevent attacks of angina (chest pain) and treatment of angina due to coronary artery disease. Angina occurs when the heart does not get a sufficient amount of oxygen. When the heart does not get enough oxygenated blood, then it is unable to function properly. If proper treatment is not provided at the right time, it can even cause heart attack, heart failure, or arrhythmias (irregular heart rhythms).
Nirowin-2.6 mg CR Tablet contains Glyceryl Trinitrate, a vasodilator in nature, which works by relaxing the blood vessels and decreasing the demand for oxygen the heart requires. As a result, it reduces heart workload and prevents attacks of angina. The dose of Nirowin-2.6 mg CR Tablet may be required to increase after a certain time as tolerance may develop after some time. Your doctor might increase the dose depending on your condition, and please stick to the dosage schedule.
Nirowin-2.6 mg CR Tablet can be taken with or without food in a dose and duration as advised by the doctor. This medicine may cause certain common side effects like dry mouth, blurred vision, insomnia, headache, dizziness, weakness, heart palpitations, low blood pressure upon rising from a seated position, nausea and vomiting, sweating, and flushing (warm or red condition of your skin). Most of these side effects are temporary and do not require medical attention. However, if the side effects persist, reach out to your doctor.
Nirowin-2.6 mg CR Tablet should be avoided if you are allergic to it. Take this medicine only if the doctor prescribes it. Never encourage self-medication or suggest your medicine to other people. Nirowin-2.6 mg CR Tablet is not recommended if you are taking medication for glaucoma, heart disease, erectile dysfunction, or anaemia. Consult your doctor before taking this medicine if you are pregnant or breastfeeding. Do not stop taking Nirowin-2.6 mg CR Tablet abruptly, as it may lead to severe side effects. Avoid alcohol consumption as it might lead to very low blood pressure.
Nirowin-2.6 mg CR Tablet contains Glyceryl Trinitrate, a vasodilator in nature. It works by relaxing the blood vessels and decreasing the demand for oxygen the heart requires. As a result, it reduces heart workload and prevents attacks of angina. The dose of Nirowin-2.6 mg CR Tablet may be required to increase after a certain time as Nirowin-2.6 mg CR Tablet develops tolerance after some time. Your doctor might increase your dose depending on your condition, and please stick to the dosage schedule.
Do not take Nirowin-2.6 mg CR Tablet if you are allergic to nitrates or its ingredients. Inform your doctor if you are taking other OTC medications, vitamins, nutritional supplements, and herbal products. If you have kidney disease, drink or have ever consumed large amounts of alcohol, have anaemia or have a heart attack, Nirowin-2.6 mg CR Tablet should be taken with caution and only if prescribed by a doctor. Tell your doctor if you are pregnant or breastfeeding before taking Nirowin-2.6 mg CR Tablet . Nirowin-2.6 mg CR Tablet may cause dizziness, light-headedness, and fainting when you get up too quickly from a lying position; hence take care and rise slowly from a sitting or lying position.
Drug-Drug Interactions: This medicine may have an interaction with any medicines that are used to treat angina, heart failure, or an irregular heartbeat, anticoagulant medications (warfarin), anti-depressant medications (bupropion), migraine medicines (ergotamine), erectile dysfunction medication (alprostadil, avanafil, sildenafil, tadalafil, vardenafil), blood thinners (aspirin), NSAIDs (naproxen, ibuprofen), and tricyclic antidepressants (amitriptyline, desipramine, doxepin).
Drug-Food Interactions: Limit alcohol consumption and drinks containing caffeine.
Drug-Disease Interactions: Inform your doctor if you have or ever had a myocardial infarction, congestive heart failure, anaemia, hemodialysis (a procedure where a dialysis machine and a special filter called an artificial kidney), hypotension, intracranial pressure, pericarditis (inflammation of the pericardium), hypertrophic cardiomyopathy, and glaucoma.
Angina: It is a pain in the chest and discomfort that keeps coming back as the heart does not get sufficient blood. In some cases, the pain and discomfort are also felt in the shoulders, neck, jaw, or back. Angina is a symptom of coronary artery disease. Symptoms include squeezing, pressure, a feeling of heaviness, tightness, and pain in the chest. Treatment includes lifestyle changes based on severity, angioplasty, surgery, or medications.
Alcohol
Unsafe
Concomitant use of nitrates and alcohol may cause hypotension. Hence, avoid consumption of alcohol while on treatment with Nirowin-2.6 mg CR Tablet .
Pregnancy
Consult your doctor
If you are pregnant, inform your doctor before taking Nirowin-2.6 mg CR Tablet . Your doctor may prescribe this medicine only if the benefits outweigh the risks.
Breast Feeding
Consult your doctor
If you are a breastfeeding mother, inform your doctor before taking Nirowin-2.6 mg CR Tablet . Your doctor may prescribe this medicine only if the benefits outweigh the risks.
Driving
Unsafe
Nirowin-2.6 mg CR Tablet can affect alertness and coordination. So, driving or operating machinery which requires concentration should be avoided after taking this medicine.
Liver
Caution
If you have liver problems, inform your doctor before taking Nirowin-2.6 mg CR Tablet as it may cause circulation abnormalities through the liver. Your doctor may adjust the dose if necessary based on your condition.
Kidney
Caution
If you have kidney problems, inform your doctor before taking Nirowin-2.6 mg CR Tablet . Your doctor may adjust the dose if necessary based on your condition.
Children
Unsafe
Nirowin-2.6 mg CR Tablet is not recommended for children and adolescents under 18 years of age as the safety and efficacy have not been established.
Country of origin
Manufacturer/Marketer address
Product Substitutes